BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24223792)

  • 1. Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.
    Malhotra U; Zaidi AH; Kosovec JE; Kasi PM; Komatsu Y; Rotoloni CL; Davison JM; R C; Irvin ; Hoppo T; Nason KS; Kelly LA; Gibson MK; Jobe BA
    PLoS One; 2013; 8(11):e78343. PubMed ID: 24223792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
    Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
    Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of PARP6 or survivin promotes cell apoptosis and inhibits cell invasion of colorectal adenocarcinoma cells.
    Wang H; Li S; Luo X; Song Z; Long X; Zhu X
    Oncol Rep; 2017 Apr; 37(4):2245-2251. PubMed ID: 28260087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells.
    Cogno IS; Vittar NB; Lamberti MJ; Rivarola VA
    J Photochem Photobiol B; 2011 Sep; 104(3):434-43. PubMed ID: 21641815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
    Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
    Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles in esophageal adenocarcinoma.
    Dahlberg PS; Ferrin LF; Grindle SM; Nelson CM; Hoang CD; Jacobson B
    Ann Thorac Surg; 2004 Mar; 77(3):1008-15. PubMed ID: 14992916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and functional implications of the inhibitor of apoptosis proteins survivin and XIAP in esophageal cancer.
    Dizdar L; Jünemann LM; Werner TA; Verde PE; Baldus SE; Stoecklein NH; Knoefel WT; Krieg A
    Oncol Lett; 2018 Mar; 15(3):3779-3789. PubMed ID: 29467895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
    Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
    Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice.
    Zhao N; Mao Y; Han G; Ju Q; Zhou L; Liu F; Xu Y; Zhao X
    Oncotarget; 2015 Jul; 6(21):18445-59. PubMed ID: 26090615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
    Rosato A; Pivetta M; Parenti A; Iaderosa GA; Zoso A; Milan G; Mandruzzato S; Del Bianco P; Ruol A; Zaninotto G; Zanovello P
    Int J Cancer; 2006 Oct; 119(7):1717-22. PubMed ID: 16671090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.
    Sun PL; Jin Y; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Virchows Arch; 2013 Sep; 463(3):427-36. PubMed ID: 23907568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
    Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
    Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma.
    Loeser H; Kraemer M; Gebauer F; Bruns C; Schröder W; Zander T; Alakus H; Hoelscher A; Buettner R; Lohneis P; Quaas A
    J Immunol Res; 2020; 2020():2862647. PubMed ID: 33029538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of Notch receptor signaling pathway induces caspase-dependent and caspase-independent apoptosis in lung squamous cell carcinoma cells.
    Cao H; Hu Y; Wang P; Zhou J; Deng Z; Wen J
    APMIS; 2012 Jun; 120(6):441-50. PubMed ID: 22583356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.
    Zhao Y; Luo A; Li S; Zhang W; Chen H; Li Y; Ding F; Huang F; Liu Z
    J Biol Chem; 2016 Mar; 291(13):6831-42. PubMed ID: 26858249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer.
    Qin S; Xu C; Li S; Wang X; Sun X; Wang P; Zhang B; Ren H
    Oncol Rep; 2015 Nov; 34(5):2656-64. PubMed ID: 26352384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.
    Goltsov AA; Fang B; Pandita TK; Maru DM; Swisher SG; Hofstetter WL
    Ann Thorac Surg; 2018 Feb; 105(2):363-370. PubMed ID: 29223420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy.
    Zhu H; Wang Q; Hu C; Zhang W; Quan L; Liu M; Xu N; Xiao Z
    Tumour Biol; 2011 Dec; 32(6):1147-53. PubMed ID: 21826474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression.
    Hoang AT; Vizio B; Chiusa L; Cimino A; Solerio D; Do NH; Pileci S; Camandona M; Bellone G
    Int J Med Sci; 2021; 18(6):1406-1414. PubMed ID: 33628097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.